XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
UNAUDITED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Total Global Payments Shareholders’ Equity
Number of Shares
Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
NonredeemableNoncontrolling Interests
Balance at beginning of period (in shares) at Dec. 31, 2021     284,750,000        
Balance at beginning of period at Dec. 31, 2021 $ 25,869,417 $ 25,628,201   $ 22,880,261 $ 2,982,122 $ (234,182) $ 241,216
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income 249,636 244,733     244,733   4,903
Other comprehensive income (loss) (18,367) (13,023)       (13,023) (5,344)
Stock issued under share-based compensation plans (in shares)     1,395,000        
Stock issued under share-based compensation plans 7,940 7,940   7,940      
Common stock repurchased - share-based compensation plans (in shares)     (195,000)        
Common stock repurchased - share-based compensation plans (26,789) (26,789)   (26,789)      
Share-based compensation expense $ 38,399 38,399   38,399      
Repurchase of common stock (in shares) (4,515,626)   (4,516,000)        
Repurchases of common stock $ (649,654) (649,654)   (561,725) (87,929)    
Distributions to noncontrolling interest (5,534)           (5,534)
Cash dividends declared (70,243) (70,243)     (70,243)    
Balance at end of period (in shares) at Mar. 31, 2022     281,434,000        
Balance at end of period at Mar. 31, 2022 25,394,805 25,159,564   22,338,086 3,068,683 (247,205) 235,241
Balance at beginning of period (in shares) at Dec. 31, 2022     263,082,000        
Balance at beginning of period at Dec. 31, 2022 22,540,210 22,303,506   19,978,095 2,731,380 (405,969) 236,704
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income (4,420) (11,041)     (11,041)   6,621
Other comprehensive income (loss) 1,526 (4,848)       (4,848) 6,374
Stock issued under share-based compensation plans (in shares)     1,014,000        
Stock issued under share-based compensation plans 6,103 6,103   6,103      
Common stock repurchased - share-based compensation plans (in shares)     (266,000)        
Common stock repurchased - share-based compensation plans (30,189) (30,189)   (30,189)      
Share-based compensation expense 89,566 89,566   89,566      
Issuance of share-based awards in connection with a business combination $ 2,484 2,484   2,484      
Repurchase of common stock (in shares) (2,058,902)   (2,059,000)        
Repurchases of common stock $ (206,553) (206,553)   (206,553)      
Distributions to noncontrolling interest (6,218)           (6,218)
Cash dividends declared (65,750) (65,750)     (65,750)    
Balance at end of period (in shares) at Mar. 31, 2023     261,771,000        
Balance at end of period at Mar. 31, 2023 $ 22,326,759 $ 22,083,278   $ 19,839,506 $ 2,654,589 $ (410,817) $ 243,481